Business Context and Reporting Period
This Form 8-K Current Report is filed by 180 Life Sciences Corp. (not Forum Markets Inc.) for the reporting date of January 31, 2022. The registrant is a Delaware corporation with principal executive offices in Palo Alto, California. The company is classified as an emerging growth company and its common stock (ATNF) and warrants (ATNFW) trade on The NASDAQ Stock Market LLC.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report serves as a disclosure vehicle for a press release and does not contain a financial statement or quantitative performance data.
Material Changes
No material changes to financial results or operations are detailed in the text of this filing. The report discloses the issuance of a press release containing a letter to stockholders from the Chief Executive Officer, Dr. James Woody.
Guidance, Outlook, and Risks
- Management Commentary: The filing references a letter to stockholders from CEO Dr. James Woody included in Exhibit 99.1, though the specific content of the letter is not reproduced in the filing text.
- Forward-Looking Statements: The press release contains forward-looking statements subject to risks and uncertainties. The company explicitly states that actual results may differ materially from projections.
- Risk Factors: The filing directs investors to the "Risk Factors" and "Management's Discussion and Analysis" sections of periodic filings (Form 10-Q and Form 10-K) for detailed information on potential factors affecting financial results.
- Legal Disclaimer: The information in Item 7.01 and Exhibit 99.1 is furnished, not filed, for purposes of Section 18 of the Exchange Act and is not incorporated by reference except as expressly stated.
Investor Verification Checklist
- Verify the content of the press release and CEO letter attached as Exhibit 99.1, as the filing text only references their existence.
- Review the company's most recent Form 10-K or 10-Q for actual financial metrics (revenue, cash flow, debt) which are absent from this 8-K.
- Confirm the trading status of the common stock (ATNF) and warrants (ATNFW) on NASDAQ.
- Note that the company is an emerging growth company, which may impact financial reporting standards and disclosure requirements.